Issue of Equity

22nd Feb 2011 13:24

Verona Pharma plc (the "Company")

22 February 2011 - London, UK - Verona Pharma plc (AIM:VRP.L)announces that following the exercise of options over ordinary shares in the Company of 0.1 pence each ("Ordinary Shares") on 5 November 2010, the Company has applied for 1,159,666 Ordinary Shares to be admitted to the AIM market of the London Stock Exchange ("Admission"). Admission is expected to occur at 8.00 a.m. on 28 February 2011.

For more information please contact:

Verona Pharma plc Tel: 020 7863 3300 Clive Page, Chairman [email protected] Michael Walker, CEO Evolution Securities Limited Tel: 020 7071 4300

Bobbie Hilliam / Tim Redfern / Patrick Castle [email protected]

College Hill Tel: 020 7457 2020 Melanie Toyne Sewell / Gemma Howe [email protected]

vendor

---

Related Shares:

VRP.L